Linda A. Miller

Interpretive criteria for testing susceptibility of staphylococci to mupirocin

J. Finlay, Linda A. Miller, James A. Poupard · Antimicrobial Agents and Chemotherapy · 1997 · 136 citations · Full text

Antimicrobial Susceptibility, Appropriate Mupirocin Susceptibility, Susceptibility Breakpoints +12

Increasing Role of <i>Staphylococcus aureus</i> and Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Infections in the United States: A 10-Year Trend of Replacement and Expansion

Robertino M. Mera, Jose A. Suaya, Heather Amrine‐Madsen et al. · Microbial Drug Resistance · 2011 · 98 citations

Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections

Karen O’Dwyer, Aaron Spivak, Karen Ingraham et al. · Antimicrobial Agents and Chemotherapy · 2014 · 97 citations · Full text

Microbial Pathogens, Escherichia Coli Isolates, Antibiotic Resistance +21

Serotype Replacement and Multiple Resistance in <i>Streptococcus pneumoniae</i> After the Introduction of the Conjugate Pneumococcal Vaccine

Robertino M. Mera, Linda A. Miller, Thomas R. Fritsche et al. · Microbial Drug Resistance · 2008 · 79 citations

Prevalence and Sequence Variation of Panton-Valentine Leukocidin in Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the United States

Megan L. Brown, F. Patrick O’Hara, Nicole M. Close et al. · Journal of Clinical Microbiology · 2011 · 74 citations · Full text

Panton-valentine Leukocidin, Usa300 Mrsa, Antimicrobial Resistance Gene +15